These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 21444894)
1. Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery. Ricome S; Provenchere S; Aubier B; Ajzenberg N; Lepage L; Dilly MP; Dufour G; Montravers P; Longrois D Circulation; 2011 Mar; 123(12):1355-7. PubMed ID: 21444894 [No Abstract] [Full Text] [Related]
2. [Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation]. Scheffler E; Aulmann M; Remppis A; Ziegler R; Martin E; Fleischer F; Nawroth P Z Kardiol; 1995 Jul; 84(7):565-8. PubMed ID: 7676727 [TBL] [Abstract][Full Text] [Related]
3. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia]. Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734 [No Abstract] [Full Text] [Related]
15. Heparin-induced thrombocytopenia and its treatment. Warkentin TE J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582 [No Abstract] [Full Text] [Related]
16. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium. Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia]. Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175 [No Abstract] [Full Text] [Related]
18. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin]. Salmi L; Leroy-Matheron C; LeBesnerais P; Rosanval O; Duvaldestin P; Gouault-Heilmann M Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322 [TBL] [Abstract][Full Text] [Related]
19. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia. Opatrny L; Warner MN Am J Hematol; 2004 Jul; 76(3):240-4. PubMed ID: 15224359 [TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients. Burkhard-Meier U; Söhngen D; Schultheiss HP; Greinacher A; Schwartzkopff B; Vogt M; Heyll A; Schneider W Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499 [No Abstract] [Full Text] [Related] [Next] [New Search]